Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Spindle activity in young children with autism, developmental delay, or typical development.

Farmer CA, Chilakamarri P, Thurm AE, Swedo SE, Holmes GL, Buckley AW.

Neurology. 2018 Jun 6. pii: 10.1212/WNL.0000000000005759. doi: 10.1212/WNL.0000000000005759. [Epub ahead of print]

PMID:
29875224
2.

Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.

Ballard ED, Yarrington JS, Farmer CA, Lener MS, Kadriu B, Lally N, Williams D, Machado-Vieira R, Niciu MJ, Park L, Zarate CA Jr.

J Affect Disord. 2018 Apr 15;231:51-57. doi: 10.1016/j.jad.2018.01.027. Epub 2018 Feb 5.

PMID:
29448238
3.

Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings.

Barterian JA, Arnold LE, Brown NV, Farmer CA, Williams C, Findling RL, Kolko DJ, Bukstein OG, Molina BSG, Townsend L, Aman MG.

J Am Acad Child Adolesc Psychiatry. 2017 Dec;56(12):1026-1033. doi: 10.1016/j.jaac.2017.09.426. Epub 2017 Oct 6.

PMID:
29173736
4.

The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders.

Findling RL, Townsend L, Brown NV, Arnold LE, Gadow KD, Kolko DJ, McNamara NK, Gary DS, Kaplin DB, Farmer CA, Kipp H, Williams C, Butter EM, Bukstein OG, Rice R Jr, Buchan-Page K, Molina BS, Aman MG.

J Child Adolesc Psychopharmacol. 2017 Feb;27(1):52-65. doi: 10.1089/cap.2016.0081.

5.

Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study.

Pardo CA, Farmer CA, Thurm A, Shebl FM, Ilieva J, Kalra S, Swedo S.

Mol Autism. 2017 Jan 5;8:1. doi: 10.1186/s13229-016-0115-7. eCollection 2017.

6.

Randomized, Controlled Trial of Intravenous Immunoglobulin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections.

Williams KA, Swedo SE, Farmer CA, Grantz H, Grant PJ, D'Souza P, Hommer R, Katsovich L, King RA, Leckman JF.

J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):860-867.e2. doi: 10.1016/j.jaac.2016.06.017. Epub 2016 Aug 3.

PMID:
27663941
7.

Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation.

Lam C, Ferreira C, Krasnewich D, Toro C, Latham L, Zein WM, Lehky T, Brewer C, Baker EH, Thurm A, Farmer CA, Rosenzweig SD, Lyons JJ, Schreiber JM, Gropman A, Lingala S, Ghany MG, Solomon B, Macnamara E, Davids M, Stratakis CA, Kimonis V, Gahl WA, Wolfe L.

Genet Med. 2017 Feb;19(2):160-168. doi: 10.1038/gim.2016.75. Epub 2016 Jul 7.

PMID:
27388694
8.

Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.

Farmer CA, Epstein JN, Findling RL, Gadow KD, Arnold LE, Kipp H, Kolko DJ, Butter E, Schneider J, Bukstein OG, McNamara NK, Molina BS, Aman MG.

J Child Adolesc Psychopharmacol. 2017 Mar;27(2):117-124. doi: 10.1089/cap.2016.0040. Epub 2016 Jun 27.

9.

Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial.

Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR Jr, Schneider J, Aman MG.

J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):469-78. doi: 10.1016/j.jaac.2016.03.014. Epub 2016 Apr 13.

10.

Confirmation of the Factor Structure and Measurement Invariance of the Children's Scale of Hostility and Aggression: Reactive/Proactive in Clinic-Referred Children With and Without Autism Spectrum Disorder.

Farmer CA, Kaat AJ, Mazurek MO, Lainhart JE, DeWitt MB, Cook EH, Butter EM, Aman MG.

J Child Adolesc Psychopharmacol. 2016 Feb;26(1):10-8. doi: 10.1089/cap.2015.0098. Epub 2016 Jan 8.

11.

Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.

Rundberg-Rivera EV, Townsend LD, Schneider J, Farmer CA, Molina BB, Findling RL, Gadow KD, Bukstein OG, Arnold LE, Kolko DJ, Buchan-Page KA, McNamara NK, Michel C, Austin A, Kipp H, Rice RR, Aman MG.

J Child Adolesc Psychopharmacol. 2015 Apr;25(3):225-33. doi: 10.1089/cap.2014.0097.

12.

Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.

Farmer CA, Brown NV, Gadow KD, Arnold LE, Kolko DG, Findling RL, Molina BS, Buchan-Page KA, Rice RR Jr, Bangalore SS, Bukstein O, Rundberg-Rivera EV, McNamara N, Aman MG.

J Child Adolesc Psychopharmacol. 2015 Apr;25(3):213-24. doi: 10.1089/cap.2014.0109.

13.

Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.

Arnold LE, Gadow KD, Farmer CA, Findling RL, Bukstein O, Molina BS, Brown NV, Li X, Rundberg-Rivera EV, Bangalore S, Buchan-Page K, Hurt EA, Rice R, McNamara NK, Aman MG.

J Child Adolesc Psychopharmacol. 2015 Apr;25(3):203-12. doi: 10.1089/cap.2014.0104.

14.

Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.

Gadow KD, Arnold LE, Molina BS, Findling RL, Bukstein OG, Brown NV, McNamara NK, Rundberg-Rivera EV, Li X, Kipp HL, Schneider J, Farmer CA, Baker JL, Sprafkin J, Rice RR Jr, Bangalore SS, Butter EM, Buchan-Page KA, Hurt EA, Austin AB, Grondhuis SN, Aman MG.

J Am Acad Child Adolesc Psychiatry. 2014 Sep;53(9):948-959.e1. doi: 10.1016/j.jaac.2014.05.008. Epub 2014 Jun 12.

15.

12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder.

Grant PJ, Joseph LA, Farmer CA, Luckenbaugh DA, Lougee LC, Zarate CA Jr, Swedo SE.

Neuropsychopharmacology. 2014 May;39(6):1453-9. doi: 10.1038/npp.2013.343. Epub 2013 Dec 19.

16.

What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder?

Aman MG, Bukstein OG, Gadow KD, Arnold LE, Molina BS, McNamara NK, Rundberg-Rivera EV, Li X, Kipp H, Schneider J, Butter EM, Baker J, Sprafkin J, Rice RR Jr, Bangalore SS, Farmer CA, Austin AB, Buchan-Page KA, Brown NV, Hurt EA, Grondhuis SN, Findling RL.

J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):47-60.e1. doi: 10.1016/j.jaac.2013.09.022. Epub 2013 Nov 18.

17.

The treatment of severe child aggression (TOSCA) study: Design challenges.

Farmer CA, Arnold LE, Bukstein OG, Findling RL, Gadow KD, Li X, Butter EM, Aman MG.

Child Adolesc Psychiatry Ment Health. 2011 Nov 10;5(1):36. doi: 10.1186/1753-2000-5-36.

18.

Aripiprazole for the treatment of irritability associated with autism.

Farmer CA, Aman MG.

Expert Opin Pharmacother. 2011 Mar;12(4):635-40. doi: 10.1517/14656566.2011.557661. Epub 2011 Feb 6. Review.

19.

Psychometric properties of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP).

Farmer CA, Aman MG.

Res Dev Disabil. 2010 Jan-Feb;31(1):270-80. doi: 10.1016/j.ridd.2009.09.014. Epub 2009 Oct 23.

PMID:
19854027
20.

Psychotropic medication research in children and adolescents: empirical findings and ethical implications.

Aman MG, Farmer CA.

J Empir Res Hum Res Ethics. 2008 Sep;3(3):39-47. doi: 10.1525/jer.2008.3.3.39.

PMID:
19385769
21.

Development of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP).

Farmer CA, Aman MG.

Res Dev Disabil. 2009 Nov-Dec;30(6):1155-67. doi: 10.1016/j.ridd.2009.03.001. Epub 2009 Apr 16.

PMID:
19375274
22.

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Aman MG, Farmer CA, Hollway J, Arnold LE.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):713-38, vii. doi: 10.1016/j.chc.2008.06.009. Review.

23.

Project MED: effects of a Medication EDucation booklet series for individuals with intellectual disabilities.

Aman MG, Benson BA, Farmer CA, Hall KL, Malone KM.

Intellect Dev Disabil. 2007 Feb;45(1):33-45.

PMID:
17428125
24.

Chest pain evaluation unit: a cost-effective approach for ruling out acute myocardial infarction.

de Leon AC Jr, Farmer CA, King G, Manternach J, Ritter D.

South Med J. 1989 Sep;82(9):1083-9. Review.

PMID:
2505390
25.

Supplemental Content

Loading ...
Support Center